The therapeutic advances in cystic fibrosis transforming patients’ lives
'I used to treat sick patients with CF, now I treat healthier people with CF gene abnormalities', says Professor John Wilson
Many people diagnosed with CF are now reaching their 50s, 60s and beyond. It’s been a therapeutic revolution.
But the new generation of gene therapies such as ivacaftor and lumacaftor will not only help patients live longer, they are also improving quality of life.
